Gerber LLC’s Pfizer PFE Stock Holding History

Gerber LLC’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-7,403	Closed	-$213K	–	104
2023 Q4	$213K	Buy	+7,403	New	+$224K	0.19%	83

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Gerber LLC's PFE Position: Q1 2024 in Review

Gerber LLC sold out of Pfizer (PFE) in Q1 2024, closing a stake of 7,403 shares — an estimated $213K sold.

Gerber LLC first reported a position in PFE in Q4 2023 and held it in 1 quarter. The position peaked at $213K in Q4 2023. 2,875 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

Gerber LLC reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
Gerber LLC sold 7,403 Pfizer shares in Q1 2024, an estimated $213K.
Gerber LLC first reported a position in Pfizer in Q4 2023 and held it in 1 quarter.
Gerber LLC's Pfizer position peaked at $213K in Q4 2023.
2,875 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on Gerber LLC's 13F filing for Q1 2024, filed 22 Apr 2024.